Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 4 studies | 20% ± 2% | |
epithelial cell | 4 studies | 21% ± 3% | |
cardiac muscle cell | 4 studies | 19% ± 2% | |
astrocyte | 4 studies | 27% ± 5% | |
GABAergic neuron | 3 studies | 47% ± 2% | |
glutamatergic neuron | 3 studies | 58% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 39% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 1885.21 | 226 / 226 | 100% | 13.38 | 406 / 406 |
brain | 100% | 1421.41 | 2641 / 2642 | 100% | 8.49 | 705 / 705 |
esophagus | 100% | 914.40 | 1444 / 1445 | 100% | 6.82 | 183 / 183 |
breast | 100% | 1188.71 | 459 / 459 | 100% | 10.68 | 1117 / 1118 |
thymus | 100% | 1361.80 | 653 / 653 | 100% | 11.20 | 604 / 605 |
bladder | 100% | 1063.24 | 21 / 21 | 100% | 10.54 | 503 / 504 |
prostate | 100% | 1109.92 | 245 / 245 | 100% | 8.77 | 501 / 502 |
ovary | 100% | 1229.73 | 180 / 180 | 100% | 14.48 | 429 / 430 |
kidney | 100% | 1367.36 | 89 / 89 | 100% | 12.04 | 898 / 901 |
uterus | 100% | 983.53 | 170 / 170 | 100% | 9.52 | 457 / 459 |
intestine | 100% | 1111.72 | 966 / 966 | 99% | 10.57 | 523 / 527 |
lung | 99% | 966.00 | 573 / 578 | 100% | 9.54 | 1154 / 1155 |
stomach | 100% | 848.36 | 358 / 359 | 99% | 8.80 | 284 / 286 |
skin | 100% | 886.74 | 1806 / 1809 | 99% | 9.53 | 468 / 472 |
pancreas | 99% | 628.38 | 326 / 328 | 99% | 7.67 | 176 / 178 |
adrenal gland | 100% | 963.80 | 257 / 258 | 98% | 6.61 | 226 / 230 |
adipose | 100% | 1126.04 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 9.39 | 29 / 29 |
muscle | 100% | 1815.39 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1570.93 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 9.01 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.29 | 1 / 1 |
blood vessel | 100% | 772.35 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 2129.02 | 855 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 11.95 | 78 / 80 |
peripheral blood | 86% | 1075.48 | 800 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010566 | Biological process | regulation of ketone biosynthetic process |
GO_0036046 | Biological process | protein demalonylation |
GO_0006476 | Biological process | protein deacetylation |
GO_2000378 | Biological process | negative regulation of reactive oxygen species metabolic process |
GO_0061698 | Biological process | protein deglutarylation |
GO_0036048 | Biological process | protein desuccinylation |
GO_0031667 | Biological process | response to nutrient levels |
GO_0007005 | Biological process | mitochondrion organization |
GO_0036049 | Biological process | peptidyl-lysine desuccinylation |
GO_0010667 | Biological process | negative regulation of cardiac muscle cell apoptotic process |
GO_0036047 | Biological process | peptidyl-lysine demalonylation |
GO_0040029 | Biological process | epigenetic regulation of gene expression |
GO_0005739 | Cellular component | mitochondrion |
GO_0005758 | Cellular component | mitochondrial intermembrane space |
GO_0005829 | Cellular component | cytosol |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005634 | Cellular component | nucleus |
GO_0003950 | Molecular function | NAD+ ADP-ribosyltransferase activity |
GO_0036055 | Molecular function | protein-succinyllysine desuccinylase activity |
GO_0061697 | Molecular function | protein-glutaryllysine deglutarylase activity |
GO_0036054 | Molecular function | protein-malonyllysine demalonylase activity |
GO_0070403 | Molecular function | NAD+ binding |
GO_0034979 | Molecular function | NAD-dependent protein lysine deacetylase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_1990404 | Molecular function | NAD+-protein ADP-ribosyltransferase activity |
Gene name | SIRT5 |
Protein name | Sirtuin (Silent mating type information regulation 2 homolog) 5 (S. cerevisiae), isoform CRA_c (Sirtuin 5) Sirtuin 5 NAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 2.3.1.-) (Regulatory protein SIR2 homolog 5) (SIR2-like protein 5) |
Synonyms | SIR2L5 DKFZp686L2375 hCG_37419 |
Description | FUNCTION: NAD-dependent lysine demalonylase, desuccinylase and deglutarylase that specifically removes malonyl, succinyl and glutaryl groups on target proteins . Activates CPS1 and contributes to the regulation of blood ammonia levels during prolonged fasting: acts by mediating desuccinylation and deglutarylation of CPS1, thereby increasing CPS1 activity in response to elevated NAD levels during fasting . Activates SOD1 by mediating its desuccinylation, leading to reduced reactive oxygen species . Activates SHMT2 by mediating its desuccinylation . Modulates ketogenesis through the desuccinylation and activation of HMGCS2 (By similarity). Has weak NAD-dependent protein deacetylase activity; however this activity may not be physiologically relevant in vivo. Can deacetylate cytochrome c (CYCS) and a number of other proteins in vitro such as UOX. . FUNCTION: NAD-dependent lysine demalonylase, desuccinylase and deglutarylase that specifically removes malonyl, succinyl and glutaryl groups on target proteins. Activates CPS1 and contributes to the regulation of blood ammonia levels during prolonged fasting: acts by mediating desuccinylation and deglutarylation of CPS1, thereby increasing CPS1 activity in response to elevated NAD levels during fasting. Activates SOD1 by mediating its desuccinylation, leading to reduced reactive oxygen species. Modulates ketogenesis through the desuccinylation and activation of HMGCS2. Has weak NAD-dependent protein deacetylase activity; however this activity may not be physiologically relevant in vivo. Can deacetylate cytochrome c (CYCS) and a number of other proteins in vitro such as Uox. . FUNCTION: NAD-dependent lysine demalonylase, desuccinylase and deglutarylase that specifically removes malonyl, succinyl and glutaryl groups on target proteins. Activates CPS1 and contributes to the regulation of blood ammonia levels during prolonged fasting: acts by mediating desuccinylation and deglutarylation of CPS1, thereby increasing CPS1 activity in response to elevated NAD levels during fasting. Activates SOD1 by mediating its desuccinylation, leading to reduced reactive oxygen species. Modulates ketogenesis through the desuccinylation and activation of HMGCS2. Has weak NAD-dependent protein deacetylase activity; however this activity may not be physiologically relevant in vivo. Can deacetylate cytochrome c (CYCS) and a number of other proteins in vitro such as Uox. . |
Accessions | A0A7P0T877 ENST00000680151.1 [Q9NXA8-1] ENST00000680442.1 ENST00000681818.1 A0A7P0Z4F6 ENST00000680402.1 ENST00000680852.1 ENST00000681012.1 ENST00000679658.1 ENST00000606427.5 ENST00000681243.1 ENST00000606117.2 [Q9NXA8-1] ENST00000681231.1 Q7Z3A0 Q9NXA8 ENST00000680754.1 U3KQT8 ENST00000397350.7 [Q9NXA8-1] ENST00000680432.1 [Q9NXA8-1] A0A7P0T915 A0A7P0T9X1 A0A7P0Z490 ENST00000359782.8 [Q9NXA8-3] A0A7P0Z4N6 A0A7P0TA05 ENST00000679922.1 ENST00000679663.1 ENST00000681905.1 ENST00000379262.8 [Q9NXA8-2] ENST00000680937.1 A0A7P0T9N1 A0A7P0TBF5 ENST00000680707.1 [Q9NXA8-2] ENST00000379250.10 |